vs
Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $351.4M, roughly 1.8× APOGEE ENTERPRISES, INC.). Royalty Pharma plc runs the higher net margin — 34.4% vs 4.7%, a 29.7% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 1.6%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 2.9%).
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
APOG vs RPRX — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $351.4M | $622.0M |
| Net Profit | $16.6M | $214.2M |
| Gross Margin | 22.4% | — |
| Operating Margin | 7.3% | 62.4% |
| Net Margin | 4.7% | 34.4% |
| Revenue YoY | 1.6% | 4.8% |
| Net Profit YoY | 568.8% | 2.9% |
| EPS (diluted) | $0.78 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $622.0M | ||
| Q3 25 | $358.2M | $609.3M | ||
| Q2 25 | $346.6M | $578.7M | ||
| Q1 25 | $345.7M | $568.2M | ||
| Q4 24 | $341.3M | $593.6M | ||
| Q3 24 | $342.4M | $564.7M | ||
| Q2 24 | $331.5M | $537.3M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $214.2M | ||
| Q3 25 | $23.6M | $288.2M | ||
| Q2 25 | $-2.7M | $30.2M | ||
| Q1 25 | $2.5M | $238.3M | ||
| Q4 24 | $21.0M | $208.2M | ||
| Q3 24 | $30.6M | $544.0M | ||
| Q2 24 | $31.0M | $102.0M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 21.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 29.8% | — |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 62.4% | ||
| Q3 25 | 7.5% | 70.1% | ||
| Q2 25 | 2.0% | 36.3% | ||
| Q1 25 | 1.8% | 94.0% | ||
| Q4 24 | 8.4% | 60.9% | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 12.5% | 50.2% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | 34.4% | ||
| Q3 25 | 6.6% | 47.3% | ||
| Q2 25 | -0.8% | 5.2% | ||
| Q1 25 | 0.7% | 41.9% | ||
| Q4 24 | 6.1% | 35.1% | ||
| Q3 24 | 8.9% | 96.3% | ||
| Q2 24 | 9.4% | 19.0% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $0.49 | ||
| Q3 25 | $1.10 | $0.67 | ||
| Q2 25 | $-0.13 | $0.07 | ||
| Q1 25 | $0.12 | $0.55 | ||
| Q4 24 | $0.96 | $0.46 | ||
| Q3 24 | $1.40 | $1.21 | ||
| Q2 24 | $1.41 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $618.7M |
| Total DebtLower is stronger | $232.3M | $9.0B |
| Stockholders' EquityBook value | $511.8M | $9.7B |
| Total Assets | $1.1B | $19.6B |
| Debt / EquityLower = less leverage | 0.45× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $618.7M | ||
| Q3 25 | $39.5M | $938.9M | ||
| Q2 25 | $32.8M | $631.9M | ||
| Q1 25 | $41.4M | $1.1B | ||
| Q4 24 | $43.9M | $929.0M | ||
| Q3 24 | $51.0M | $950.1M | ||
| Q2 24 | $30.4M | $1.8B |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | $285.0M | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $9.7B | ||
| Q3 25 | $500.2M | $9.6B | ||
| Q2 25 | $481.8M | $9.5B | ||
| Q1 25 | $487.9M | $9.8B | ||
| Q4 24 | $522.1M | $10.3B | ||
| Q3 24 | $506.4M | $10.3B | ||
| Q2 24 | $480.0M | $9.8B |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $19.6B | ||
| Q3 25 | $1.2B | $19.3B | ||
| Q2 25 | $1.2B | $18.3B | ||
| Q1 25 | $1.2B | $17.6B | ||
| Q4 24 | $1.2B | $18.2B | ||
| Q3 24 | $917.1M | $18.0B | ||
| Q2 24 | $889.0M | $17.7B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | 0.58× | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $122.5M | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 7.8% | — |
| Cash ConversionOCF / Net Profit | 7.37× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $827.1M | ||
| Q3 25 | $57.1M | $702.6M | ||
| Q2 25 | $-19.8M | $364.0M | ||
| Q1 25 | $30.0M | $596.1M | ||
| Q4 24 | $31.0M | $742.5M | ||
| Q3 24 | $58.7M | $703.6M | ||
| Q2 24 | $5.5M | $658.2M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $52.4M | — | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $50.2M | — | ||
| Q2 24 | $-1.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 14.6% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | -0.5% | — |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.2% | — |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | 3.86× | ||
| Q3 25 | 2.41× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 12.08× | 2.50× | ||
| Q4 24 | 1.48× | 3.57× | ||
| Q3 24 | 1.92× | 1.29× | ||
| Q2 24 | 0.18× | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
